drugset / Trial / NCT05870540
BPL-003 Efficacy and Safety in Treatment Resistant Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 2 study randomized, quadruple masked, multi-center study , with a Open Label Extension, designed to investigate the efficacy and safety of BPL-003 combined with psychological support in patients with treatment resistant depression (TRD).
Timeline
- Start
- 2023-09-14
- Primary completion
- 2025-03-28
- Completion
- 2025-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BPL-003 | Unknown | — | Intranasal |
Indications
No indication recorded.